CRLBFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Cresco Labs Inc.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 6, 2026
$0.58−0.02 (-3.13%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q4 FY2024 Ended Dec 31, 2024 | Mar 12, 2025 | During market hours | $176.00M | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Mar 13, 2024 | During market hours | $188.00M | – | – |
| Q4 FY2022 Ended Dec 31, 2022 | Mar 16, 2023 | After market close | – | – | – |
| Q4 FY2021 Ended Dec 31, 2021 | Apr 1, 2022 | During market hours | – | – | – |
Press releases
Announcements Cresco Labs filed with the SEC
EX-99.1 to Form 6-K
EX-99.1 to Form 6-K
EX-99.1 to Form 6-K
EX-99.1 to Form 6-K
Notice of Availability of Proxy Materials
EX-99.2 to Form 6-K
UNAUDITED CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS
EX-99.1 to Form 6-K
UNAUDITED CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS
EX-99.1 to Form 6-K
Cresco Labs Establishes At-the-Market Offering
EX-99.2 to Form 6-K
UNAUDITED CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS
EX-99.1 to Form 6-K
SENIOR SECURED TERM LOAN AGREEMENT
EX-99.1 to Form 6-K
Cresco Labs Closes $325 Million Senior Secured Term Loan Refinancing
EX-99.2 to Form 6-K
NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING
EX-99.1 to Form 6-K
Notice of Availability of Proxy Materials
EX-99.2 to Form 6-K
UNAUDITED CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS
EX-99.1 to Form 6-K
NOTICE OF CHANGE OF AUDITOR
EX-99.1 to Form 6-K
EX-99.2 to Form 6-K
EX-99.2 to Form 6-K
EX-99.3 to Form 6-K
EX-99.3 to Form 6-K
UNAUDITED CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS
EX-99.1 to Form 6-K
Cresco Labs Continues Track Record of Delivering Strong Operating Cash Flow
EX-99.3 to Form 6-K
UNAUDITED CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS
EX-99.1 to Form 6-K
Report of Foreign Private Issuer
EX-99.1 to Form 6-K
Cresco Labs Announces Dennis Olis to Retire as Chief Financial Officer
EX-99.1 to Form 6-K
UNAUDITED CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS
EX-99.1 to Form 6-K